Skip to Main Content

Paper Details

Anti-Tumor Necrosis Factor α versus Tocilizumab in the Treatment of Refractory Uveitic Macular Edema: A Multicenter Study from the French Uveitis Network.
Ophthalmology
23
2022
Author NameAffiliation
Bahram BodaghiPitie Salpetriere Hospital, Sorbonne Universite
  • 1 - 1

Datasets

Release 1.2